Defective Lamtor5 Leads to Autoimmunity by Deregulating v‐ATPase and Lysosomal Acidification
Advanced Science · 2024
DOI: 10.1002/advs.202400446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Wei Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210046, China. Hauptthemen laut MEDLINE: Autoimmunity, Lupus Erythematosus, Systemic, Lysosomes, Vacuolar Proton-Translocating ATPases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technologies Research and Development Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Despite accumulating evidence linking defective lysosome function with autoimmune diseases, how the catabolic machinery is regulated to maintain immune homeostasis remains unknown. Late endosomal/lysosomal adaptor, MAPK and mTOR activator 5 (Lamtor5) is a subunit of the Ragulator mediating mechanistic target of rapamycin complex 1 (mTORC1) activation in response to amino acids, but its action mode and physiological role are still unclear. Here it is demonstrated that Lamtor5 level is markedly decreased in peripheral blood mononuclear cells (PBMCs) of patients with systemic lupus erythematosus (SLE). In parallel, the mice with myeloid Lamtor5 ablation developed SLE‐like manifestation. Impaired lysosomal function and aberrant activation of mTORC1 are evidenced in Lamtor5 deficient macrophages and PBMCs of SLE patients, accompanied by blunted autolysosomal pathway and undesirable inflammatory responses. Mechanistically, it is shown that Lamtor5 is physically associated with ATP6V1A, an essential subunit of vacuolar H + ‐ATPase (v‐ATPase), and promoted the V0/V1 holoenzyme assembly to facilitate lysosome acidification. The binding of Lamtor5 to v‐ATPase affected the lysosomal tethering of Rag GTPase and weakened its interaction with mTORC1 for activation. Overall, Lamtor5 is identified as a critical factor for immune homeostasis by intergrading v‐ATPase activity, lysosome function, and mTOR pathway. The findings provide a potential therapeutic target for SLE and/or other autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nanjing University of Chinese Medicine, Nanjing, 210046, China.
- Key lab of Artificial Organs and Computational Medicine, Institute of Translational Medicine, Zhejiang Shuren University, Hangzhou, 310022, China.
- School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
- The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China.
- Department of Infectious Diseases, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China.
- Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210093, China.
Förderung
- Key Technologies Research and Development Program
- National Natural Science Foundation of China
Zitieren
APA
Zhang, W., Sha, Z., Tang, Y., Jin, C., Gao, W., Chen, C., Yu, L., Lv, N., Liu, S., Xu, F., Wang, D., & Shi, L. (2024). Defective Lamtor5 Leads to Autoimmunity by Deregulating v‐ATPase and Lysosomal Acidification. Advanced Science. https://doi.org/10.1002/advs.202400446
Vancouver
Zhang W, Sha Z, Tang Y, Jin C, Gao W, Chen C, et al. Defective Lamtor5 Leads to Autoimmunity by Deregulating v‐ATPase and Lysosomal Acidification. Advanced Science. 2024. doi:10.1002/advs.202400446
BibTeX
@article{Zhang2024,
author = {Zhang, Wei and Sha, Zhou and Tang, Yunzhe and Jin, Cuiyuan and Gao, Wenhua and Chen, Changmai and Yu, Lang and Lv, Nianyin and Liu, Shijia and Xu, Feng and Wang, Dandan and Shi, Liyun},
title = {Defective Lamtor5 Leads to Autoimmunity by Deregulating v‐ATPase and Lysosomal Acidification},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202400446}
}
EUVIMED